Literature DB >> 12657860

Sub-Tenon anesthesia: a prospective study of 6,000 blocks.

Philip A Guise1.   

Abstract

BACKGROUND: An initial pilot study of 300 sub-Tenon local anesthetic blocks (STBs) for intraocular surgery established the effectiveness and patient acceptability of the technique. Following this, a decision was made in 1995 to change from sharp needle techniques to STB for all eye surgeries performed during local anesthesia at Auckland Hospital (Auckland, New Zealand) by reeducation of anesthetists and surgeons. At this point, sufficient data were not available to confirm that STB would avoid the complications associated with the passage of sharp needles into the orbit or would cause a different set of serious complications.
METHODS: A prospective study of the next 6,000 consecutive STBs performed at Auckland Hospital was carried out over a period of 6 yr (from 1995 to 2000).
RESULTS: Sub-Tenon block is very effective, with a surgeon and patient acceptability rate of 98.8%. Insertion of the sub-Tenon cannula and administration of the anesthetic produces minimal discomfort, being completely painless in 68.8% of cases. There were no serious block-related complications in this series, supporting the safety of the sub-Tenon technique.
CONCLUSION: The experience at Auckland Hospital provides further support for the avoidance of passing sharp needles into the orbit.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12657860     DOI: 10.1097/00000542-200304000-00025

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  20 in total

1.  Hyaluronidase in sub-Tenon's anesthesia for phacoemulsification, a double-blind randomized clinical trial.

Authors:  Mohammadreza Sedghipour; Ali Mahdavifard; Rohollah Fadaei Fouladi; Davoud Gharabaghi; Mohammadbagher Rahbani; Ghasem Amiraslanzadeh; Mohammadreza Afhami
Journal:  Int J Ophthalmol       Date:  2012-06-18       Impact factor: 1.779

2.  New onset atrial fibrillation following sub-Tenon's anaesthesia.

Authors:  Elliott Y Ah-Kee; James F Li Yim
Journal:  Int J Ophthalmol       Date:  2013-12-18       Impact factor: 1.779

3.  Visual impact of sub-Tenon anesthesia during combined phacoemulsification and vitrectomy surgery.

Authors:  Wei-Qi Chen; Vishal Jhanji; Hao-Yu Chen; Gui-Hua Zhang; Ping Hou
Journal:  Int J Ophthalmol       Date:  2014-10-18       Impact factor: 1.779

4.  Intraoperative head drift and eye movement: two under addressed challenges during cataract surgery.

Authors:  Kerr Brogan; Basu Dawar; David Lockington; Kanna Ramaesh
Journal:  Eye (Lond)       Date:  2018-02-21       Impact factor: 3.775

5.  Fine cannula technique for sub-Tenon's injection for ophthalmic anaesthesia.

Authors:  A El-Khayat; M Wakefield; P Boddy; J Prydal
Journal:  Eye (Lond)       Date:  2018-01-05       Impact factor: 3.775

6.  Evaluating the effectiveness of localized sub-Tenon's anesthesia in 23-gauge vitreoretinal surgery.

Authors:  Atilla Alpay; Tuncer Güney
Journal:  Int Ophthalmol       Date:  2020-09-09       Impact factor: 2.031

7.  Effect of clonidine added to lidocaine for sub-Tenon's (episcleral) anesthesia in cataract surgery.

Authors:  Sigmar Aurea Cabral; Antonio Roberto Carraretto; Marcos Celio Brocco; João Florêncio Abreu Baptista; Renato Santiago Gomez
Journal:  J Anesth       Date:  2014-02       Impact factor: 2.078

Review 8.  Sub-Tenon's anaesthesia: complications and their prevention.

Authors:  C M Kumar; H Eid; C Dodds
Journal:  Eye (Lond)       Date:  2011-04-01       Impact factor: 3.775

Review 9.  Anaesthesia for cataract surgery.

Authors:  Emmanuel Nouvellon; Philippe Cuvillon; Jacques Ripart; Eric J Viel
Journal:  Drugs Aging       Date:  2010-01-01       Impact factor: 3.923

10.  Efficacy of sub-Tenon's block using an equal volume of local anaesthetic administered either as a single or as divided doses. A randomised clinical trial.

Authors:  Ehtesham I Khan; Jawad Mustafa; John McAdoo; George Shorten
Journal:  BMC Anesthesiol       Date:  2009-03-26       Impact factor: 2.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.